Literature DB >> 15902301

Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities.

Angelina J Lay1, Zhong Liang, Elliot D Rosen, Francis J Castellino.   

Abstract

Anticoagulant protein C (PC) is important not only for maintenance of normal hemostasis, but also for regulating the host immune response during inflammation. Because mice with a designed total genetic deficiency in PC (PC-/- mice) die soon after birth, attempts to dissect PC function in various coagulation/inflammation-based pathologies through use of mice with less than 50% of normal PC levels have not been successful to date. In the current investigation, we have used a novel transgenic strategy to generate different mouse models expressing 1-18% of normal PC levels. In contrast to PC-/- mice, mice with only partial PC deficiency survived beyond birth and also developed thrombosis and inflammation. The onset and severity of these phenotypes vary significantly and are strongly dependent on plasma PC levels. Our findings additionally provide the first evidence that maternal PC is vital for sustaining pregnancy beyond 7.5 days postcoitum, likely by regulating the balance of coagulation and inflammation during trophoblast invasion. These low PC-expressing transgenic mouse lines provide novel animal models that can be used to elucidate the importance of PC in maintenance of the organism and in disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902301      PMCID: PMC1089798          DOI: 10.1172/JCI24030

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Anticoagulant properties of bovine plasma protein C following activation by thrombin.

Authors:  W Kisiel; W M Canfield; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

2.  Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.

Authors:  N L Esmon; W G Owen; C T Esmon
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

3.  High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia.

Authors:  M G van Pampus; G A Dekker; H Wolf; P C Huijgens; M M Koopman; B M von Blomberg; H R Büller
Journal:  Am J Obstet Gynecol       Date:  1999-05       Impact factor: 8.661

4.  Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis.

Authors:  Jean-François Dhainaut; S Betty Yan; Benjamin D Margolis; José A Lorente; James A Russell; Ross C Freebairn; Herbert D Spapen; Hanno Riess; Bruce Basson; Gerald Johnson; Gary T Kinasewitz
Journal:  Thromb Haemost       Date:  2003-10       Impact factor: 5.249

Review 5.  High frequency of congenital thrombophilia in women with pathological pregnancies?

Authors:  Ase Rasmussen; Pernille Ravn
Journal:  Acta Obstet Gynecol Scand       Date:  2004-09       Impact factor: 3.636

6.  Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes.

Authors:  Martina Brueckmann; Ursula Hoffmann; Lothar De Rossi; Hans Martin Weiler; Volker Liebe; Siegfried Lang; Jens J Kaden; Martin Borggrefe; Karl K Haase; Guenter Huhle
Journal:  Cytokine       Date:  2004-05-07       Impact factor: 3.861

Review 7.  Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation.

Authors:  Marlies Van de Wouwer; Désiré Collen; Edward M Conway
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-06-03       Impact factor: 8.311

8.  A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model.

Authors:  Jorge G Ganopolsky; Francis J Castellino
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

9.  Preparation and properties of bovine factor VIII (antihemophilic factor).

Authors:  G A Vehar; E W Davie
Journal:  Biochemistry       Date:  1980-02-05       Impact factor: 3.162

Review 10.  Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectiveness.

Authors:  Michael Haley; Xizhong Cui; Peter C Minneci; Katherine J Deans; Charles Natanson; Peter Q Eichacker
Journal:  Curr Opin Infect Dis       Date:  2004-06       Impact factor: 4.915

View more
  23 in total

1.  Generation and phenotypic analysis of protein S-deficient mice.

Authors:  François Saller; Anne C Brisset; Svetlana N Tchaikovski; Monica Azevedo; Roman Chrast; José A Fernández; Marc Schapira; Tilman M Hackeng; John H Griffin; Anne Angelillo-Scherrer
Journal:  Blood       Date:  2009-06-30       Impact factor: 22.113

Review 2.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

3.  Deficiency of superoxide dismutase impairs protein C activation and enhances susceptibility to experimental thrombosis.

Authors:  Sanjana Dayal; Sean X Gu; Ryan D Hutchins; Katina M Wilson; Yi Wang; Xiaoyun Fu; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-11       Impact factor: 8.311

Review 4.  Coagulopathies and inflammatory diseases: '…glimpse of a Snark'.

Authors:  Silvina Del Carmen; Sophie M Hapak; Sourav Ghosh; Carla V Rothlin
Journal:  Curr Opin Immunol       Date:  2018-09-27       Impact factor: 7.486

5.  Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency.

Authors:  Angelina J Lay; Deborah Donahue; Meng-Ju Tsai; Francis J Castellino
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

Review 6.  Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C.

Authors:  Arun Paul Amar; Abhay P Sagare; Zhen Zhao; Yaoming Wang; Amy R Nelson; John H Griffin; Berislav V Zlokovic
Journal:  Neuropharmacology       Date:  2017-09-18       Impact factor: 5.250

7.  S2'-subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor -2 domain1-wild-type, Leu17Arg-mutant and aprotinin.

Authors:  K Vadivel; Y Kumar; G I Ogueli; S M Ponnuraj; P Wongkongkathep; J A Loo; M S Bajaj; S P Bajaj
Journal:  J Thromb Haemost       Date:  2016-11-19       Impact factor: 5.824

8.  Antibody SPC-54 provides acute in vivo blockage of the murine protein C system.

Authors:  Laurent Burnier; José A Fernández; John H Griffin
Journal:  Blood Cells Mol Dis       Date:  2013-02-04       Impact factor: 3.039

Review 9.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

10.  Effect of microgravity on gene expression in mouse brain.

Authors:  Antonio Frigeri; Dumitru A Iacobas; Sanda Iacobas; Grazia Paola Nicchia; Jean Francois Desaphy; Diana Conte Camerino; Maria Svelto; David C Spray
Journal:  Exp Brain Res       Date:  2008-08-14       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.